Jones Renee, Carville Kylie, James Rodney
University of Melbourne School of Population Global Health (Master of Public Health student project), 207 Bouverie Street, Carlton, VIC 3053, Australia.
Victorian Infectious Diseases Reference Laboratory, Doherty Institute, 792 Elizabeth St, Melbourne VIC 3000, Australia.
JAC Antimicrob Resist. 2020 Dec 4;2(4):dlaa100. doi: 10.1093/jacamr/dlaa100. eCollection 2020 Dec.
There is little information on the prevalence and type of antimicrobial stewardship (AMS) activities that are currently occurring in Australian hospitals.
To determine what AMS activities are currently occurring in Australian hospitals, identify gaps in compliance with the Australian Commission on Safety and Quality in Health Care (ACSQHC) standards and determine perceived barriers and enablers for implementing AMS programmes.
A cross-sectional survey open to all Australian hospitals, conducted online and available to hospitals between November 2016 and July 2017.
Responses were received from 254 hospitals. Compliance with ACSQHC AMS essential activities was high, except for essential activity 3 (post-prescription reviews), which was conducted by only 39% of respondent hospitals. Importantly, compliance varied by hospital remoteness classification for all activities except essential activity 1 (availability and endorsement of guidelines) and additional activity 4 (publishing antimicrobial susceptibility data annually), with major city hospitals having the highest compliance across all activities. The three most frequently reported barriers to implementing AMS programmes were a lack of training and education, lack of pharmacy resources and a lack of willingness from medical officers to change.
Due to low response rates from certain hospital groups, the survey results are not generalizable to all Australia hospitals. This survey has identified that several gaps in compliance still exist and outlines the need to address lower AMS compliance in hospitals located outside major cities. The key barriers and enablers for AMS programme implementation identified should be used to inform future strategies.
关于澳大利亚医院目前正在开展的抗菌药物管理(AMS)活动的患病率和类型的信息很少。
确定澳大利亚医院目前正在开展哪些AMS活动,找出在符合澳大利亚医疗保健安全与质量委员会(ACSQHC)标准方面存在的差距,并确定实施AMS计划的感知障碍和推动因素。
对所有澳大利亚医院开展的一项横断面调查,通过网络进行,于2016年11月至2017年7月期间可供医院参与。
收到了254家医院的回复。除基本活动3(处方后审查)外,对ACSQHC AMS基本活动的合规率很高,只有39%的受访医院开展了基本活动3。重要的是,除基本活动1(指南的可用性和认可)和附加活动4(每年公布抗菌药物敏感性数据)外,所有活动的合规率因医院偏远程度分类而异,大城市医院在所有活动中的合规率最高。实施AMS计划最常报告的三个障碍是缺乏培训和教育、缺乏药学资源以及医务人员缺乏改变的意愿。
由于某些医院群体的回复率较低,调查结果不能推广到所有澳大利亚医院。这项调查发现仍然存在一些合规差距,并概述了有必要解决大城市以外医院较低的AMS合规问题。所确定的AMS计划实施的关键障碍和推动因素应用于为未来战略提供信息。